Aarti Industries Ltd Q3 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/e4e2y8d3mrl9vpkj6oej1g8h.pdf

Key Takeaways


The Two Contracts: Visibility, Not Reinvention

Rajendra Gogri: "We are more than happy that this has come though in such a challenging macro environment which underscores our commitment to transforming relationships into sustainable long-term opportunities."

Demand Environment: A Two-Speed Recovery


Margins: The Gross Profit Per Kg Framework

Rajendra Gogri: "On gross margin we never even evaluate our business model. Basically, it is always gross profit per kg for a particular product. This is the major criteria for us."

Operating Leverage & The Path to 18-20% Margins

Rajendra Gogri: "Yes, that's what we have been highlighting for a year or so because the operating leverage will kick in and conversion of gross profit to EBITDA will be high and that with the constant raw material prices, our EBITDA as a percentage also progressively should go up."

Chlorotoluenes: The FY27 Catalyst


Balance Sheet & Capital Allocation


Guidance & Commitments

CommitmentSpecificsTimeline
FY24 EBITDACloser to ₹1,000 crore (revised from ₹950-1,000 crore)FY24 close
FY25 EBITDA₹1,450-1,700 croreFY25
FY25 volume growth20-25% on composite basisFY25
EBITDA margin target18-20% when revenue reaches ~₹9,000 croreAt ~₹9,000 cr revenue
Demand normalisationWidespread recovery across segmentsNext 1-2 quarters
Agrochemical recoveryProgressive QoQ improvement starting Q4 FY24Q4 FY24 onwards
Discretionary demandFurther improvement expectedQ4 FY24 onwards
Chlorotoluenes commissioningPhased commissioning beginsFY26
Chlorotoluenes EBITDA contributionSizable EBITDA expectedFY27 onwards
Contract 2 revenue ramp₹1,500 crore (from ~₹900 crore in FY24)FY25
Contract 1 revenue ramp~₹300 crore in FY25, ₹350 crore+ at full run-rateFY25 / FY26+
Capex deployment₹2,500-3,000 crore total between FY24-FY25FY24-FY25
Existing site expansions completionVapi, current Jhagadia, DahejCalendar year 2024
FY25 gross debt₹3,500-3,800 crore (assuming stable RM prices)FY25
FY25 tax rate15-17%FY25

Key Metrics

MetricQ3 FY24
Consolidated revenue₹1,889 cr, +18% QoQ
Consolidated EBITDA (incl. other income)₹268 cr, +15% QoQ
Profit after tax₹124 cr, +36% QoQ
EBITDA margin~14.2% (₹268 cr on ₹1,889 cr, per an analyst's math); management expects movement toward 18–20% at higher turnover
FY24 EBITDA guidance~₹1,000 cr, revised from ₹950–1,000 cr earlier
FY25 EBITDA guidance₹1,450–1,700 cr
9M FY24 CAPEX₹860 cr
FY24–FY25 planned CAPEX₹2,500–3,000 cr combined
Nitrochlorobenzene production19,580 MT, vs 18,199 MT YoY and 19,014 MT QoQ
Hydrogenation production3,644 TPM, vs 2,995 TPM YoY and 3,136 TPM QoQ
Nitro-Toluene production6,951 MT, vs 7,528 MT YoY and 7,560 MT QoQ
PDA volume481 tonnes per month
Discretionary vs non-discretionary mix~60% discretionary, ~40% non-discretionary; prior period ~50:50
FY25 volume growth target (composite)20–25%
Long-term agrochemical contract revenue potentialOver ₹3,000 cr over 9 years; FY25 ~₹300 cr, FY26 onwards ₹350 cr+
4-year specialty chemical contract valueOver ₹6,000 cr; FY24 to FY25 revenue jump from ~₹900 cr to ₹1,500 cr
Chlorotoluene chain revenue target₹2,000 cr plus; EBITDA margin 25–30%
FY25 estimated gross debt₹3,500–3,800 cr
FY25 estimated tax rate15–17%